α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation

Journal of Investigative Dermatology

Volumn 132, Issue 7, 2012, Pages 1814-1824

  Auriemma, Matteo ^a,c   Brzoska, Thomas ^a   Klenner, Lars ^a   Kupas, Verena ^a   Goerge, Tobias ^a   Voskort, Maik ^a   Zhao, Zuotao ^a   Sparwasser, Tim ^b   Luger, Thomas A ^a   Loser, Karin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; SKIN INFLAMMATION; SKIN PIGMENTATION; TH17 CELL;

EID: 84862328377     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.59     Document Type: Article

References (49)

1. Adler HS, Steinbrink K (2007) Tolerogenic dendritic cells in health and disease: friend and foe!. Eur J Dermatol 17:476-91 (Pubitemid 350207158)
2. Andersen GN, Hägglund M, Nagaeva O et al. (2005) Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol 61:279-84 (Pubitemid 40462779)
3. Banchereau J, Briere F, Caux C et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-11
4. Barton GM, Medzhitov R (2003) Toll-like receptor signaling pathways. Science 300:1524-5 (Pubitemid 36682871)
5. Böhm M, Schulte U, Kalden H et al. (1999) Alpha-melanocyte- stimulating hormone modulates activation of NF-kappa B and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann NY Acad Sci 885:277-86
6. Botchkarev VA, Botchkareva NV, Slominski A et al. (1999) Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann NY Acad Sci 885:433-9
7. Brzoska T, Luger TA, Maaser C et al. (2008) Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29:581-602
8. Catania A, Lonati C, Sordi A et al. (2010) The melanocortin system in control of inflammation. Scient World J 10:1840-53
9. Chhajlani V, Wikberg JES (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309:417-20
10. Clark RA (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130:362-70
11. Cone RD, Lu D, Koppula S et al. (1996) The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 51:287-317 (Pubitemid 126476618)
12. Cooper A, Robinson SJ, Pickard C et al. (2005) α-Melanocyte- stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 175:4806-13 (Pubitemid 41362024)
13. Delgado M, Chorny A, Gonzalez-Rey E et al. (2005a) Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. J Leukoc Biol 78:1327-38 (Pubitemid 41779239)
14. Delgado M, Gonzalez-Rey E, Ganea D (2005b) The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 175:7311-24 (Pubitemid 41713427)
15. Elliott RJ, Szabo M, Wagner MJ et al. (2004) α-Melanocyte- stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 122:1010-9 (Pubitemid 38581004)
16. Gee K, Guzzo C, Che Mat NF et al. (2009) The IL-12 family cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8:40-52
17. Girard-Madoux MJ, Kel JM, Reizis B et al. (2012) IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. J Allergy Clin Immunol 129:143-50
18. Gonzalez-Rey E, Fernandez-Martin A, Chorny A et al. (2006) Vasoactive intestinal peptide induces CD4+, CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum 54:864-76
19. Grabbe S, Bhardwaj RS, Mahnke K et al. (1996) α-Melanocyte- stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156:473-8
20. Guilliams M, Crozat K, Henri S et al. (2010) Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 115:1958-68
21. Han D, Tian Y, Zhang M et al. (2007) Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated α-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther 14:383-95
22. Hill RP, MacNeil S, Haycock JW (2006) Melanocyte stimulating hormone peptides inhibit TNF-alpha signaling in human dermal fibroblast cells. Peptides 27:421-30 (Pubitemid 43162914)
23. Ichiyama T, Sakai T, Catania A et al. (1999) Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol 99:211-7 (Pubitemid 29518233)
24. Ko JM, Gottlieb AB, Kerbleski JF (2009) Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatol Treat 20:100-8
25. Lahl K, Loddenkemper C, Drouin C et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204:57-63 (Pubitemid 46148756)
26. Loser K, Brzoska T, Oji V et al. (2010) The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans. PLoS One 5:e8958
27. Loser K, Mehling A, Loeser S et al. (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12:1372-9 (Pubitemid 44924495)
28. Luger TA, Brzoska T (2007) Alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis 66(Suppl 3):iii52-5 (Pubitemid 350032635)
29. Luger TA, Brzoska T, Scholzen TE et al. (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann NY Acad Sci 917:232-8
30. Ma HL, Liang S, Li J et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597-607 (Pubitemid 351206549)
31. Ma HL, Napierata L, Stedman N et al. (2010) Tumor necrosis factor α blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum 62:430-40
32. Maaser C, Kannengiesser K, Specht C et al. (2006) Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55:1415-22 (Pubitemid 44476784)
33. Mahnke K, Johnson TS, Ring S et al. (2007) Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 46:159-67 (Pubitemid 46601842)
34. Mahnke K, Qian Y, Knop J et al. (2003) Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101:4862-9 (Pubitemid 36857748)
35. Maldonado RA, von Andrian UH (2010) How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 108:111-65
36. Min Y, Han D, Fu Z et al. (2011) α-MSH inhibits TNF-α-induced maturation of human dendritic cells in vitro through the up-regulation of ANXA1. Acta Biochim Biophys Sin 43:61-8
37. Mountjoy KG, Robbins LS, Mortrud MT et al. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-50
38. Nestle FO, Di Meglio P, Qin JZ et al. (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9:679-91
39. Raap U, Brzoska T, Sohl S et al. (2003) α-Melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171:353-9 (Pubitemid 36745308)
40. Rennalls LP, Seidl T, Larkin JM et al. (2010) The melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells. Immunology 129:610-9
41. Robbins LS, Nadeau JH, Johnson KR et al. (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72:827-34 (Pubitemid 23110225)
42. Rudman D, Hollins BM, Kutner MH et al. (1983) Three types of alpha-melanocyte-stimulating hormone: bioreactivities and half-lives. Am J Physiol 245:E47-54 (Pubitemid 14230305)
43. Sabat R, Philipp S, Höflich C et al. (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779-98 (Pubitemid 47377643)
44. Sugiyama H, Gyulai R, Toichi E et al. (2005) Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174:164-73 (Pubitemid 40007402)
45. Taylor A, Namba K (2001) In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 79:358-67 (Pubitemid 32744282)
46. Thornton AE, Korty PE, Tran DQ et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184:3433-41
47. van der Fits L, Mourits S, Voerman JS et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836-45
48. Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523-32
49. Yun WJ, Lee DW, Chang SE et al. (2010) Role of CD4CD25FOXP3 regulatory T cells in psoriasis. Ann Dermatol 22:397-403